Example: Heart Attack

Clinical Trials on Polycystic Kidney Diseases

Total 143 results

NCT03423810

Completed

Assessing a Dose-Response Relationship of Hydralazine and Its Effects on DNA Methyltransferase 1 in Polycystic Kidney Disease Patients

Conditions: Polycystic Kidney Diseases
NCT02558595

Completed

Pilot Study of Niacinamide in Polycystic Kidney Disease (NIAC-PKD2)

Conditions: Polycystic Kidney Disease
NCT03948113

Completed

Outcome of Autosomal Dominant Polycystic Kidney Disease Patients on Peritoneal Dialysis: a National Retrospective Study Based on Two French Registries (the French Language Peritoneal Dialysis Registry and the French Renal Epidemiology and Information Network).

Conditions: Polycystic Kidney Diseases
NCT04284657

Recruiting

Pravastatin and Alkali Therapy in Patients With Autosomal Dominant Polycystic Kidney Disease

Conditions: Autosomal Dominant Polycystic Kidney Disease
NCT02140814

Completed

Uncontrolled, Open Label, Pilot and Feasibility Study of Niacinamide in Polycystic Kidney Disease

Conditions: Polycystic Kidney Disease
NCT00792155

Recruiting

Polycystic Kidney Disease Data Repository

Conditions: Polycystic Kidney Disease
NCT02933268

Completed

High Water Intake in Polycystic Kidney Disease

Conditions: Autosomal Dominant Polycystic Kidney Disease
NCT04064346

Not yet recruiting

Efficacy and Safety of Lixivaptan in the Treatment of Autosomal Dominant Polycystic Kidney Disease

Conditions: Polycystic Kidney Disease, Adult
NCT02127437

Completed

Lanreotide In Polycystic Kidney Disease Study

Conditions: Autosomal Dominant Polycystic Kidney Disease (ADPKD
NCT04152837

Recruiting

Safety of Lixivaptan in Subjects Previously Treated With Tolvaptan for Autosomal Dominant Polycystic Kidney Disease

Conditions: Polycystic Kidney Disease, Adult
NCT01988038

Withdrawn

Repository Study of Autosomal Dominant Polycystic Kidney Disease

Conditions: Autosomal Dominant Polycystic Kidney Disease
NCT03901521

Active, not recruiting

Autosomal Dominant Polycystic Kidney Disease Somatic Mutation Biorepository

Conditions: Autosomal Dominant Polycystic Kidney Disease
NCT02697617

Completed

Use of Low Dose Pioglitazone to Treat Autosomal Dominant Polycystic Kidney Disease

Conditions: Polycystic Kidney Disease
NCT04536688

Recruiting

A Study of RGLS4326 in Patients With Autosomal Dominant Polycystic Kidney Disease

Conditions: Polycystic Kidney Disease, Autosomal Dominant
NCT04344769

Recruiting

Characterization of the Nrf2 Response in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Conditions: Autosomal Dominant Polycystic Kidney Disease
NCT01039987

Completed

Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease

Conditions: Autosomal Dominant Polycystic Kidney Disease
NCT04578548

Recruiting

A Study to Evaluate the Effects of GLPG2737 in Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Conditions: Autosomal Dominant Polycystic Kidney Disease
NCT00286156

Completed

Pilot Study of Rapamycin as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Conditions: Polycystic Kidney Diseases
NCT03487913

Completed

The ELiSA Study - Evaluation of Lixivaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease

Conditions: Autosomal Dominant Polycystic Kidney Disease
NCT01451827

Completed

8-Week Study of Tolvaptan Dose Forms in Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Conditions: Autosomal Dominant Polycystic Kidney Disease
NCT02134899

Completed

The Efficacy of Everolimus in Reducing Total Native Kidney Volume in Polycystic Kidney Disease Transplanted Recipients

Conditions: Autosomal Dominant Polycystic Kidney Disease
NCT01377246

Completed

Somatostatin In Patients With Autosomal Dominant Polycystic Kidney Disease And Moderate To Severe Renal Insufficiency

Conditions: Autosomal Dominant Polycystic Kidney Disease
NCT02964273

Active, not recruiting

Safety, Pharmacokinetics, Tolerability and Efficacy of Tolvaptan in Children and Adolescents With ADPKD (Autosomal Dominant Polycystic Kidney Disease)

Conditions: Autosomal Dominant Polycystic Kidney Disease (ADPKD)
NCT00414440

Completed

Efficacy, Safety and Tolerability of Everolimus in Preventing End-stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease

Conditions: Autosomal Dominant Polycystic Kidney Disease
NCT02746419

Withdrawn

The Safety and Efficacy of Catheter-based Renal Denervation Using the Vessix™ Renal Denervation System in Autosomal Dominant Polycystic Kidney Disease (ADPKD) Patients With Severe Debilitating Pain

Conditions: Autosomal Dominant Polycystic Kidney Disease